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SUMMArY
Sleep disturbances in patients with lung cancer in Turkey
Introduction: Sleep quality is known to be associated with the distressing symptoms of cancer. The purpose of this study was to 
analyze the impact of cancer symptoms on insomnia and the prevalence of sleep-related problems reported by the patients with lung 
cancer in Turkey.
Materials and Methods: Assesment of Palliative Care in Lung Cancer in Turkey (ASPECT) study, a prospective multicenter study 
conducted in Turkey with the participation of 26 centers and included all patients with lung cancer, was re-evaluated in terms of sleep 
problems, insomnia and possible association with the cancer symptoms. Demographic characteristics of patients and information 
about disease were recorded for each patient by physicians via face-to-face interviews, and using hospital records. Patients who have 
difficulty initiating or maintaining sleep (DIMS) is associated with daytime sleepiness/fatigue were diagnosed as having insomnia. 
Daytime sleepiness, fatigue and lung cancer symptoms were recorded and graded using the Edmonton Symptom Assessment Scale.
results: Among 1245 cases, 48.4% reported DIMS, 60.8% reported daytime sleepiness and 82.1% reported fatigue. The prevalence 
of insomnia was 44.7%. Female gender, patients with stage 3-4 disease, patients with metastases, with comorbidities, and with weight 
loss > 5 kg had higher rates of insomnia. Also, patients with insomnia had significantly higher rates of pain, nausea, dyspnea, and 
anxiety. Multivariate logistic regression analysis showed that patients with moderate to severe pain and dyspnea and severe anxiety 
had 2-3 times higher rates of insomnia.
conclusion: In conclusion, our results showed a clear association between sleep disturbances and cancer symptoms. Because of that, 
adequate symptom control is essential to maintain sleep quality in patients with lung cancer.
Key words: Lung cancer; sleep disturbance; insomnia; symptom; pain; dyspnea
ÖzeT
Türkiye’de akciğer kanseri hastalarında uyku bozuklukları
Giriş: Uyku kalitesinin, kanser semptomlarının şiddetiyle ilişkili olduğu bilinmektedir. Bu çalışmada, Türkiye’de akciğer kanseri hasta-
larında uyku ile ilişkili sorunların prevalansı ve kanser semptomlarının insomnia üzerine etkisinin araştırılması amaçlandı. 
Materyal ve Metod: Türkiye’de 26 merkezin katılımıyla gerçekleştirilen, akciğer kanserli olguların dahil edildiği çok merkezli bir çalış-
ma olan ASPECT çalışması verileri, bu hastalarda görülen uyku sorunları, insomni ve bunların kanser semptomları ile ilişkisi yönüyle 
yeniden değerlendirildi. Hastaların demografik özellikleri ve hastalıkları hakkında bilgi, hasta ile yüz yüze görüşülerek ve hastane 
kayıtları aracılığıyla derlendi. Uykuyu başlatma ve sürdürme zorluğu (DIMS) ile gündüz artmış uyku hali veya yorgunluk tanımlayan 
olgular insomni olarak değerlendirildi. Gündüz uyku hali, yorgunluk ve akciğer kanseri semptomları Edmonton Semptom 
Değerlendirme Skalası kullanılarak kaydedildi.
Bulgular: Katılan 1245 olgunun, %48.4’ünde DIMS, %60.8’inde gündüz uyku hali ve %82.1’inde yorgunluk mevcuttu. Insomni 
prevalansı %44.7 olarak bulundu. Kadın cinsiyet, evre 3-4 hastalık, metastatik hastalık, komorbid hastalıklar ve kilo kaybı > 5 kg olan 
olgularda insomnia oranı anlamlı olarak daha yüksekti. Diğer yandan insomnisi olan hastalarda ağrı, bulantı, dispne ve anksiyete 
semptomları anlamlı düzeyde yüksek bulundu. Multivariate lojistik regresyon analizi, orta ileri şiddetli ağrısı ve dispnesi olan, ayrıca 
ciddi anksiyetesi olan hastalarda insomni sıklığının 2-3 kat fazla olduğunu ortaya koydu. 
Sonuç: Çalışmamız, kanser semptomları ile uyku kalitesi arasında yakın bir ilişki olduğunu ortaya koymuştur. Bu nedenle, akciğer kanserli 
hastalarda kaliteli bir uyku için, kanser semptomların yeterince kontrol edilmesi gereklidir.
Anahtar kelimeler: Akciğer kanseri; uyku bozukluğu; insomni; semptom; ağrı; dispne
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INTrodUcTIoN
Sleep disturbances, such as difficulty falling asleep and 
maintaining sleep, early awakening, and excessive 
daytime sleepiness, are common in patients with 
cancer. Of the cancer patients, 30-75% report sleep 
problems, which is a rate about two times as high as in 
the general population (1). Specifically, in patients with 
lung cancer, 52% of newly diagnosed lung cancer 
patients were found to have insomnia (2). Sleep quality 
is known to be associated with the distressing symptoms 
of cancer (3). Inadequately controlled or uncontrolled 
cancer symptoms lead to disturbed and fragmented 
sleep which may contribute to poor quality of life and 
mood disorders, particularly depression (1).  
Several studies have reported that there is a high 
prevalence of uncontrolled symptoms in patients with 
lung cancer (4,5). In a previous study, we have also 
shown that palliative treatment of lung cancer 
symptoms are mostly inadequate, and large number of 
patients continue to suffer from uncontrolled symptoms 
and unmet needs (6). Despite exiting data on 
association of sleep quality and symptoms in other 
cancer types, few studies, with limited number of 
patients, focused on this issue in lung cancer. We 
re-evaluated the results of this study to analyze the 
impact of cancer symptoms on insomnia and the 
prevalence of sleep-related problems reported by the 
patients with lung cancer in Turkey.
MATerIALS and MeTHodS 
Study design
Assessment of Palliative Care in Lung Cancer in Turkey 
(ASPECT) study is a prospective multicenter study con-
ducted in Turkey (between March 2014-September 
2014) with the participation of 26 centers, including 
all patients with lung cancer, who agreed to participate 
in the study (6). The study was approved by the local 
ethics committee and written informed consent was 
obtained from all patients. The results of ASPECT study 
were re-evaluated in terms of sleep disturbances and 
possible association with the cancer symptoms.
Patients and Setting
The study included all consecutive patients with lung 
cancer, whom disease was objectively confirmed his-
topathologically. Demographic characteristics of 
patients and information about disease were recorded 
for each patient by physicians via face-to-face inter-
views, and using hospital records.
Patients were questioned regarding whether or not 
they had difficulty initiating or maintaining sleep 
(DIMS): “Do you frequently have difficulty in falling 
asleep at night or waking up frequently during the 
night or getting back to sleep after waking during the 
night?” Patients with DIMS also expressed subjective 
reasons for DIMS as open ended questions. Daytime 
sleepiness, fatigue and lung cancer symptoms were 
recorded and graded using the Edmonton Symptom 
Assessment Scale (ESAS) (7). The ESAS symptom scores 
were categorized by severity as follows: none= 0; 
mild= 1-3; moderate= 4-6; and severe= 7-10. Patients 
who have DIMS and associated daytime sleepiness/ 
fatigue were diagnosed as having insomnia. 
Statistical Analysis
Data analysis was performed using SPSS software 
(Version 13.01; SPSS Inc., Chicago, IL, USA). The chi-
kare test was used to compare categorical variables. 
The parametric Student t-test was used for comparing 
mean or median values of normally distributed data, 
and the nonparametric Mann-Whitney U test was used 
to compare data that was not normally distributed. 
Demography and the symptoms that were potential 
predictors of insomnia were analyzed using logistic 
regression and multivariate logistic regression analysis 
was used as a stepwise descending method from 
predictive factors with a significance ≤ 0.05 in the 
univariate analysis.
reSULTS
Among 1245 cases (88.7% man) included, 48.4% 
(590/1218 pts) reported DIMS, 60.8% (742/1221 pts) 
reported daytime sleepiness and 82.1% (1002/1220) 
reported fatigue. The most frequent subjective reasons, 
reported by the patients, for DIMS were pain and dys-
pnea (Table 1). 
The prevalence of patients with insomnia was 44.7% 
(541/1211 pts). Among demographic parameters, 
Table 1. Subjective reasons for difficulty initiating or  
maintaining sleep cited by the patients with lung cancer
reasons (590 pts) No (%)
Pain 220 (37.3)
Dyspne 164 (27.8)
Anxiety/stress/depression 95 (16.1)
Nocturia 70 (11.8)
Cough 33 (5.6)
Other 54 (9.1)
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female patients, patients with stage 3 and 4 disease, 
patients with metastases, with comorbidities, and with 
weight loss more than 5 kg had higher rates of insom-
nia (Table 2). Also, lung cancer symptoms were clearly 
associated with insomnia. Patients with insomnia had 
significantly higher rates of pain, nausea, dyspnea, and 
anxiety (Table 3). Multivariate logistic regression anal-
ysis showed a clear association between insomnia and 
symptoms: pain, dyspnea and anxiety. Especially 
patients with moderate to severe pain and dyspnea 
and severe anxiety had 2 to 3 times higher rates of 
insomnia (Table 4).
dIScUSSIoN
Insomnia is a sleep disorder characterized by repeated 
difficulty initiating sleep, difficulty maintaining sleep, 
or waking up to early which results in daytime impair-
ment despite adequate time and opportunity for sleep 
(8). Estimations of the insomnia prevalence depend on 
the criteria used to define insomnia; however a gener-
al consensus has developed from population-based 
studies that approximately 6-10% of patients have 
insomnia (9). The results of this study showed that a 
Table 3. Distribution of symptoms according to the patients 
with/without insomnia
Symptoms
Patients without
insomnia
No (%)
Patients with
insomnia
No (%) p
Pain
-No
-Yes
295 (44.0%)
375 (56.0%)
122 (22.6%)
417 (77.4%)
< 0.001
Nausea
-No
-Yes
418 (62.5%)
251 (37.5%)
244 (45.3%)
295 (54.7%)
< 0.001
Dyspnea
-No
-Yes
272 (40.7%)
397 (59.3%)
100 (18.9%)
439 (81.4%)
< 0.001
Depression
-No
-Yes
405 (60.5%)
264 (39.5%)
186 (34.5%)
353 (65.5%)
< 0.001
Anxiety
-No
-Yes
358 (53.4%)
312 (46.6%)
154 (28.6%)
385 (71.4%)
< 0.001
Table 4. Multivariate logistic regression analysis of  
demography and symptoms predicting insomnia
variables* or 95.0% cI p
Gender 1.273 0.829 - 1.954 0.270
comorbidity 1.176 0.897 - 1.542 0.239
Weight loss > 5 kg 1.301 0.989 - 1.710 0.060
Stage 3-4 disease 1.311 0.852 - 2.018 0.218
Metastasis 1.319 0.966 - 1.802 0.081
Pain REF
Mild
Moderate
Severe
0.904
2.520
3.354
0.628 - 1.303
1.732 - 3.666
2.207 - 5.098
0.589
< 0.001
< 0.001
Nausea REF
Mild
Moderate
Severe
0.980
1.245
1.622
0.688 - 1.397
0.827 - 1.873
0.968 - 2.717
0.913
0.294
0.066
dyspne REF
Mild
Moderate
Severe
1.354
2.060
2.888
0.929 - 1.974
1.402 - 3.028
1.921 - 4.341
0.115
< 0.001
< 0.001
depression REF
Mild
Moderate
Severe
1.081
1.286
1.597
0.686 - 1.704
0.748 - 2.213
0.838 - 3.045
0.737
0.363
0.155
Anxiety REF
Mild
Moderate
Severe
0.979
1.115
2.145
0.624 - 1.534
0.659 - 1.888
1.174 - 3.920
0.925
0.685
0.013
* Only variables, derived from predictive factors with a 
significance ≤ 0.05 in the univariate analysis, were included.
Table 2. Demographic parameters according to the patients 
with/without insomnia
variables
Patients
without
insomnia
No (%)
Patients with
insomnia
No (%) p
Age (mean ± SD) 61.82 ± 9.45 61.76 ± 9.34 0.920
Gender 
-Man
-Woman
610 (91.0)
60 (9.0)
467 (86.3)
74 (13.7)
0.009
BMI (mean ± SD) 24.80 ± 4.50 24.48 ± 4.63 0.119
Histopathologic type
-Small
-NSCLC
123 (18.4)
547 (81.6)
111 (20.5)
430 (79.5)
0.344
Time from diagnosis  
(mean ± SD, months)
8.99 ± 14.47 9.13 ± 13.27 0.794
Comorbidity
-No
-Yes
387 (58.2)
278 (41.8)
263 (48.7)
277 (51.3)
0.001
Family cancer history
-No
-Yes
468 (70.6)
195 (29.4)
347 (65.6)
182 (34.4)
0.066
Weight loss > 5 kg
-No
-Yes
381 (57.2)
285 (42.8)
231 (42.8)
309 (57.2)
< 0.001
Disease stages
-Stage 1-2
-Stage 3-4 
140 (21.5)
510 (78.5)
58 (11.0)
469 (89.0)
< 0.001
Metastases
-No
-Yes
357 (53.7)
308 (46.3)
189 (35.1)
350 (64.9)
< 0.001
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significant percentage of patients with lung cancer 
had poor sleep quality; insomnia (44.7%), daytime 
sleepiness (60.8%) and fatigue (82.1%). Ginsburg et 
al.  reported similar results of insomnia in (52%) 
newly diagnosed lung cancer patients (2). Also, the 
prevalence of insomnia was reported to be as 31% 
among women patients with lung cancer (10). Chen 
at al.  reported that about half of all lung cancer 
patients, receiving chemotherapy, were poor sleepers 
(11).
In current study, we found a significant correlation 
between insomnia and some demographic parame-
ters. Female gender, patients with stage 3 and 4 dis-
ease, with metastases, with comorbidities, and 
patients with weight loss more than 5 kg had higher 
rates of insomnia. Again, we found that patients with 
insomnia had significantly higher rates of pain, nau-
sea, dyspnea, and anxiety/depression. However, 
multivariate logistic regression analysis showed that 
only moderate to severe pain and dyspnea, and 
severe anxiety were the parameters predicting insom-
nia among lung cancer patients. Pain, dyspnea and 
anxiety/depression were also the most frequent sub-
jective reasons of DIMS as reported by the patients. 
The relationship between sleep quality and the dis-
tressing symptoms of cancer is not surprising and 
several studies showed that some demographic 
parameters (including patients’ gender, age, previous 
sleep history, cancer stage) and symptoms (due to 
cancer, chemotherapy and radiotherapy) were asso-
ciated with the sleep problems in general cancer 
patients (3,12-14). The association between sleep 
quality and the lung cancer symptoms has also been 
studied in a few studies and they emphasized a rela-
tionship between sleep quality and pain, vomiting, 
fatigue and dyspnea and cough (11,15,16). Despite 
we found significantly higher rates of nausea in 
patients with insomnia, logistic regression analysis 
failed to show this association. On contrary, Akyüz at 
al. reported a significant correlation between sleep 
quality and nausea and fatigue (15). The difference 
between both studies might be associated with limit-
ed number of patients in the study by Akyüz et al. 
(15). Despite we found a relation between insomnia 
and distressing cancer symptoms, it is a complex 
process and each of these symptoms can aggravate 
the others, for example; unresolved symptoms, such 
as pain, dyspnea, fatigue etc. can lead to depression, 
anxiety and impaired quality of life which in turn can 
cause sleep disturbances and insomnia.
This study has some limitations. First of all, the results 
of this study primarily based on self-reported sleep 
disturbances with no objective measures, such as 
polysomnography or actigraphy. Second, we did not 
evaluate the effect of medications and treatment on 
sleep. Finally diagnosis of insomnia limited to those 
with DIMS and daytime sleepiness and fatigue. 
However in addition to daytime sleepiness and 
fatigue, other parameters leading daytime impair-
ment such as attention/concentration/memory 
impairment, mood disturbance or irritability, motiva-
tion/energy reduction etc. were not questioned (8). 
Because of that, the rate of insomnia in this study 
might be a little bit higher than we found. 
We concluded that high percentage of patients with 
lung cancer suffer from sleep disturbances, such as 
insomnia, daytime sleepiness and fatigue. Sleep dis-
turbances in lung cancer patients were associated 
with cancer symptoms and especially pain, dyspnea 
and anxiety. Because there was a clear association 
between sleep disturbances and cancer symptoms, 
adequate symptom control is essential to maintain 
sleep quality in patients with lung cancer. We also 
conclude that, patients with lung cancer should be 
routinely evaluated for cancer symptoms: pain, dys-
pnea, and anxiety to restore sleep problems.
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